×

Tissue conduction communication (TCC) transmission

  • US 9,636,511 B2
  • Filed: 01/23/2015
  • Issued: 05/02/2017
  • Est. Priority Date: 01/23/2015
  • Status: Active Grant
First Claim
Patent Images

1. An implantable cardioverter defibrillator (ICD) configured to transmit a tissue conduction communication (TCC) signal, the ICD comprising:

  • a housing;

    a plurality of electrodes; and

    a signal generator within the housing, the signal generator comprising;

    a shock module coupled to the plurality of electrodes, wherein the shock module is configured to generate an anti-tachyarrhythmia shock and deliver the anti-tachyarrhythmia shock to a patient via the plurality of electrodes; and

    a TCC transmitter module coupled to the plurality of electrodes, wherein the TCC transmitter module is configured to generate the TCC signal and transmit the TCC signal via the plurality of electrodes, wherein the TCC signal comprises a biphasic signal having an amplitude and a frequency, wherein at least one of the amplitude or the frequency is configured to avoid stimulation of tissue of the patient by the TCC signal, and wherein the TCC transmitter module comprises;

    a power source configured to deliver current having the amplitude to the plurality of electrodes;

    polarity switching circuitry coupled to the power source, wherein the polarity switching circuitry is configured to switch the polarity of the current at the frequency; and

    protection circuitry coupled between the power source and the plurality of electrodes, wherein the protection circuitry is configured to protect the TCC transmitter module and other circuitry within the housing of the ICD from an anti-tachyarrhythmia shock delivered to the patient by the shock module or an external device, and a standoff voltage of the protection circuitry is greater than 2000 volts (V).

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×